Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean, including your options for first-line glucose-lowering therapies, when you should be screened for diabetes, the expanded use of diabetes care technology, and more. Continue Reading »

For relatives of people with type 1 diabetes (T1D), about 5% have certain antibodies associated with causing T1D. By joining this clinical trial, you or your relatives could contribute to the future of prevention and early treatment of T1D. Continue Reading »

Over the past year, diaTribe has continued to work towards our goal to create and publish helpful information to improve the lives of people with diabetes. From vaccine rollout to new medications and the latest in diabetes tech, read our 10 most popular articles from 2021. Continue Reading »

For years, people with diabetes have sought out an accurate way to measure glucose without the need for fingersticks or fluid samples. Here’s a look at the latest in research and development of non-invasive glucose monitoring devices. Continue Reading »

Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging measurement, currently being researched, that combines seven of your CGM metrics, including TIR, into a numeric score that your healthcare provider can use to quickly identify areas for adjustments within your glucose management. Continue Reading »

How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated with a lower risk of nerve damage in people with diabetes. Continue Reading »

Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications. Continue Reading »

A follow up to the MOBILE study, which demonstrated improvements in A1C and Time in Range for continuous glucose monitoring system (CGM) users with type 2 diabetes, shows that discontinuing CGM can erase these improvements.  Continue Reading »

Pages